During our 100+ years as a full-service, growth investment bank, we‘ve empowered our clients’ success by delivering a depth and breadth of insights across a broad range of sectors and capabilities.
May 5, 2023
Best ESG Investment Ideas for 2023
Read More >
Ahead of the Curve®
Dec 15, 2022
Obesity Market Poised to Deliver on Outsized Potential
Read More >
Ahead of the Curve®
Oct 13, 2022
Generalist’s Guide to Vetting Smid-Cap Biotech: Bear Market Edition
Read More >
Ahead of the Curve®
Sep 27, 2022
Trials & Triumphs of the FDA: What Matters? Where are We?
Read More >
Ahead of the Curve®
Mar 8, 2022
This Biotech Bear Market Too Shall Pass
Read More >
Ahead of the Curve®
Feb 17, 2022
ABCs of ADCs: Investor Primer on Antibody Drug Conjugates
Read More >
Ahead of the Curve®
Nov 16, 2021
Trials and Triumphs of Gene Editing: A Compendium
Read More >
Ahead of the Curve®
Sep 15, 2021
An Investor’s Guide to Bispecific Antibodies
Read More >
Ahead of the Curve®
Mar 31, 2021
Investor’s Guide to Immuno-Oncology: Focus on Novel Targets
Read More >
Ahead of the Curve®
Feb 1, 2021
Trials and Triumphs of Gene Therapy: A Compendium
Read More >
Ahead of the Curve®
Dec 4, 2020
The ABCs of ADCs: Investor Primer on Antibody Drug Conjugates
Read More >
Ahead of the Curve®
Sep 9, 2020
Why We Are Optimistic on COVID-19 Vaccines and Therapeutic Antibodies
Read More >
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.
